Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Clinical trial NCT07055893 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07055893
Sponsor: Sinovac Biotech Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Rabies (Healthy Volunteers)

Start date: 2026-03-01
Primary completion: 2027-01-30
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.